Timing of Immune Checkpoint Inhibitor Administration Affects Small Cell Lung Cancer Survival

MONDAY, Dec. 8, 2025 -- For patients with extensive-stage small cell lung cancer (ES-SCLC), administration of immune checkpoint inhibitor (ICI) therapy earlier in the day is associated with improved survival, according to a study published online...